Course syllabus for Product Development in Life Sciences
Versions of this syllabus:
Essential data
Specific entry requirements
A Bachelor's degree or a professional degree equivalent to a Swedish Bachelor's degree of at least 180 credits in health care, biomedicine, biology, cellular and molecular biology, pharmaceutics, chemistry, medicine, biotechnology, or the equivalent. Proficiency in English equivalent to the Swedish upper secondary school course English 6/English level 2.
At least the grade Pass for the courses 'Theory in Bioentrepreneurship' and 'Communication in Bioentrepreneurship 1' within the Master's programme in Bioentrepreneurship.
Proficiency in English equivalent to the Swedish upper secondary school course English 6/English level 2.
Outcomes
This course aims to introduce the students to the product development process in the life science sector where 'product' refers to technologies included within pharmaceuticals/biotechnology, medical technology and digital health.
Upon completion of the course, the student should be able to:
- perform basic product development the life science sector,
- relate product innovations to economic, ethical and technological aspects,
- account for quality control systems and standards used in product development,
- understand how the product development process differs between pharmaceuticals and medical devices,
- carry out advanced tasks within specified time limits,
- evaluate product-related risks and clearly describe and argue for the role of national as well as international regulatory bodies in influencing product development,
- assess and compare different types of intellectual property and patent strategies as well as perform basic intellectual property analyses,
Content
This course deals with the process of product development in the life science sector. Emphasis is put on the legal and regulatory frameworks of product development. This includes patents and other forms of protection of intellectual property rights and the national and international regulatory frameworks assuring product quality and patient safety.
**Course modules **
Context of product development
The component will among other things cover the following content:
The product development process for pharmaceuticals and medical devices,
Technological tools and methods used in Life Science product development,
Cost-effectiveness and evidence requirements in relation to product development,
Regulatory requirements in relation to the product development process.
Product development project
This component will among other things cover the following content:
- The Stanford Biodesign process,
- The product development process in selected fields of the life science sector,
- Create a prototype using a product development process,
- Intellectual Property Rights,
- The regulatory process within the life science sector,
- Business Model Canvas.
Teaching methods
The course will consist of lectures, workshops and project work.
The course is offered at master’s level, where the students are assumed to be familiar with the most common study methods in higher education. The course’s pedagogical approach is based on entrepreneurial learning and requires active student participation.
Examination
The examination of Component 1 (Context for product development) consists of
- a report (Fail/Pass),
- a written examination (Fail/Pass/Pass with distinction)
The examination of Component 2 (Product development project) consists of a project report from a teamwork (Fail/Pass),
To get the grade "Pass" on the entire course, the student needs to get the grade "Pass" on all examinations in both components. To get a "Pass with distinction" on the entire course, the student needs to get the grade "Pass with distinction" on the written exam in component 1, and the grade "Pass" on all other examinations. Submission of written examinations after the deadline will result in the student missing the chance to get the grade "Pass with distinction."
Compulsory participation
The examiner assesses if and, in that case, how absence from compulsory components can be compensated. The student must participate in all compulsory parts or compensate for absence in accordance with the examiner's instructions, in order to pass the course. Absence from a compulsory activity may result in the student not being able to compensate the absence until the next time the course is given.
Limited number of examinations
Students who have not passed the regular examination are entitled to participate in five more examinations. If the student has not passed the exam after four participations, they are encouraged to visit the study advisor. If the student has failed six examinations/tests, no additional examination or new admission is provided.
Physically attending or otherwise commencing an examination is regarded as an examination session. An examination, for which the student registered but did not participate, is not counted as an examination session.
In the event of special circumstances, or if a student with a disability is in need of certain adjustments, the examiner may decide to depart from the syllabus' regulations on examination form, number of examination opportunities, possibility of completion or exemption from compulsory educational elements, etc. Content and intended learning outcomes as well as the level of expected skills, knowledge and abilities must not be altered, removed or lowered.
Other directives
Course evaluation is carried out according to the guidelines that are established by the Committee for Higher Education.
Teaching and examination language is English.
Literature and other teaching aids
Mandatory literature
Note that the latest edition of the course literature is always used.
- Yock, Paul G., Biodesign: the process of innovating medical technologies, Second edition : Cambridge : Cambridge University Press, 2015. - xiii, 839 p. ISBN: 9781107087354 (hardback), LIBRIS-ID: 18269103
- Drug discovery and development: technology in transition, Hill, Raymond G.; Richards, Duncan B., Third edition : Amsterdam : Elsevier, [2022] - 373 pages ISBN: 9780702078040, LIBRIS-ID: r596b43kp01xgcw2